Home > Insider Trading > Filing (0000904454-14-000512)

Filing Details

Accession Number:: 0000904454-14-000512
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-06-12 19:27:34
Reporting Period:: 2014-06-10

Filing Date:: 2014-06-12
Accepted Time:: 2014-06-12 19:27:34
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1499807	K2M Group Holdings Inc.	KTWO	Surgical & Medical Instruments & Apparatus (3841)	000000000

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1212994	M Jonathan Rather	C/O Welsh, Carson, Anderson &Amp; Stowe 320 Park Avenue, Suite 2500 New York NY 10022	No	No	Yes	No
1212997	Scott D Mackesy	C/O Welsh, Carson, Anderson &Amp; Stowe 320 Park Avenue, Suite 2500 New York NY 10022	No	No	Yes	No
1212999	Sean Traynor	C/O Welsh, Carson, Anderson &Amp; Stowe 320 Park Avenue, Suite 2500 New York NY 10022	Yes	No	No	No
1317659	Michael Donovan	C/O Welsh, Carson, Anderson And Stowe 320 Park Avenue, Suite 2500 New York NY 10022	No	No	Yes	No
1413863	J. Eric Lee	C/O Welsh, Carson, Anderson &Amp; Stowe 320 Park Avenue, Suite 2500 New York NY 10022	No	No	Yes	No
1414384	Thomas Scully	C/O Welsh, Carson, Anderson &Amp; Stowe 320 Park Avenue, Suite 2500 New York NY 10022	No	No	Yes	No
1434789	F Anthony Ecock	C/O Welsh, Carson, Anderson &Amp; Stowe 320 Park Avenue, Suite 2500 New York NY 10022	No	No	Yes	No
1437914	Welsh, Carson, Anderson & Stowe Xi, L.p.	C/O Welsh, Carson, Anderson &Amp; Stowe 320 Park Avenue, Suite 2500 New York NY 10022	No	No	Yes	No
1556077	Thomas Brian Regan	C/O Welsh, Carson, Anderson &Amp; Stowe 320 Park Avenue, New York, Suite 2500 NY 10022	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2014-06-10	806,554	$15.00	21,879,386	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him.
Each Reporting Owner listed below also indirectly beneficially owns 320,372 shares of Common Stock held by WCAS Capital Partners IV, L.P. Such individuals are managing members of the sole general partner of WCAS Capital Partners IV, L.P. Such individuals may also be deemed to indirectly beneficially own 73,734 shares of Common Stock held by WCAS XI Co-Investors LLC. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by each such entity, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him.
Jonathan M. Rather also indirectly beneficially owns 17,914 shares of Common Stock held by WCAS Management Corp, of which he is the sole controlling shareholder. Pursuant to Instruction 4(b)(iv) of Form 4, Mr. Rather has elected to report as indirectly beneficially owned the entire number of securities owned by such entity, however he disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him.
Shares sold pursuant to the exercise of the underwriters' over-allotment option in connection with the Issuer's initial public offering.